INS and metabolic syndrome: Impaired pancreatic insulin secretion, dyslipidemia, and defects in the insulin signaling pathway in the skeletal muscle and adipose tissue that relate to the altered glucose–insulin handling and a higher prevalence of increased fetal adiposity and fetal macrosomia were observed in women with GDM [3,4,5,6].